Navigation Links
OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
Date:4/23/2012

SAN DIEGO, April 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe. The study demonstrated the therapy's ability to provide local tumor control and quality of life outcomes that compare favorably to standard outcomes associated with surgery. These results were presented at the 5th European Conference on Head and Neck Oncology in Poznan, Poland on Friday, April 20, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

The primary goal of this phase IV head and neck cancer study was to assess the ability of the OMS ElectroChemotherapy to control growth or recurrence of the cancer eight months following treatment, equivalent to surgery as compared to historical controls, with respect to primary (new) tumors and locally recurrent tumors. In this interim analysis, local tumor control was achieved in 46/49 (94%) primary tumors and 12/21 (57%) recurrent tumors. This meant that there was no recurrence of the tumors during the monitoring period. These were excellent results that were on par with the expected outcomes of surgery. Furthermore, evaluation of safety using the OMS ElectroChemotherapy for this patient population demonstrated that the treatment was safe and well-tolerated with no grade three or higher adverse events related to treatment reported during this study.

In addition, the secondary endpoint of preservation of organ function and appearance using validated quality of life instruments demonstrated a positive
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. OncoSec Selected to Present Data at Upcoming Head and Neck Cancer Conferences
2. OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial
3. OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy
4. OncoSecs OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper
5. OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
6. OncoSec to Present at World Cancer Immunotherapy Conference
7. OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
8. OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference
9. OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies
10. OncoSec to Present at Medical Device Investor Forum
11. Device Master File for OncoSec Medical System Completed and Submitted to FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Ardelyx, Inc. (NASDAQ: ... gastrointestinal and cardio-renal diseases, today announced that Sanofi ... and license agreement for Ardelyx,s portfolio of NaP2b ... payment associated with termination and the return of ... Sanofi entered into an option and license agreement ...
(Date:9/1/2015)... 1, 2015 Emerus Holdings, a national ... inpatient and diagnostic care in partnership with leading ... definitive agreement to receive a strategic investment from ... leading health care investment firm. Emerus ... acute episodic and ambulatory clinical services to communities ...
(Date:9/1/2015)... --  Alpha Imaging LLC , a leading distributor of advanced medical ... that they have been awarded exclusive rights to represent the complete ... new territory supplements Alpha Imaging,s existing Shimadzu sales and service responsibilities ... , Indiana , Pennsylvania , ... West Virginia , Delaware and ...
Breaking Medicine Technology:Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3Alpha Imaging Expands Shimadzu Territory 2
... at Brigham and Women,s,Hospital found that patients taking cannabinoid ... were unrelated to relief from their pain,symptoms. Results ... the addictive,potential of this class of pain medicine, were ... Annual Meeting. , In the ...
... The Netherlands, January 28 ,Amsterdam Molecular Therapeutics ... of,human gene therapy, announced today during the ... showing that one treatment of its lead ... and clinically important,lowering of the incidence of ...
Cached Medicine Technology:Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief 2AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly 2AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly 3
(Date:9/1/2015)... London, UK (PRWEB) , ... ... ... are constantly seeking better therapeutic options to efficiently cure and prevent different ... classes. Different cancers have different pathophysiological properties due to which distinctive approach ...
(Date:9/1/2015)... ... 01, 2015 , ... Splashtop Inc. , the worldwide ... , a solution optimized for MSPs and IT professionals looking for a cost ... inadequate customer services of existing remote support solution, many MSPs and ITs have ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and resolves ... treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Jerry Segal Classic to ... Club and Green Valley Country Club in Lafayette Hill, PA. Over the past 26 ... $13.5 million for programs and services designed to support patients and their families during ...
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, a leading global provider ... it has hired Scott Sanderson, an experienced business development professional and former NFL ... responsible for establishing and managing new client relationships in the Southeast U.S. ...
Breaking Medicine News(10 mins):Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 2Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 3Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 4Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2
... at Johns Hopkins and the University of Michigan have developed ... ,The findings will be published in the ... of Sciences. The study has implications for treating people who ... in which nerves are wrenched from the spinal cord. The ...
... Body mass index (BMI), which is the ratio of height and ... patients. A lower BMI is associated with a lesser weight// and ... with obesity and its allied health risks. , ... that measure how the weight is distributed on the body are ...
... charity organization it was shocking to find that about three-quarters ... of chronic obstructive pulmonary disease (COPD). , The ... disease. COPD is UK’s fifth-biggest killer disease as it affects ... deaths a year. The medical charity organization called the Developing ...
... Department of Health have admitted that some nursing homes do ... This does not concur with the existing legislation. ,Fine ... on more illegal charges was worrying. "It is absolutely disgraceful ... the income of a spouse of a long-stay public nursing ...
... Hospital, gauged the cost-benefit of shifting the responsibility of caring ... said that there was no major economic savings in such ... the driving force behind the idea of such a shift, ... 220 senior patients, recouping from illness, that there were not ...
... Medical education in Australia is getting caught in a number ... a wake up call. This coupled with dwindling// numbers of ... the field of healthcare education. ,Australian Medical Association president ... that parents and students will borrow, scrimp and save in ...
Cached Medicine News:Health News:Scientists Coax Nerve Fibers to Regrow After Spinal Cord Injury 2Health News:Scientists Coax Nerve Fibers to Regrow After Spinal Cord Injury 3Health News:Scientists Coax Nerve Fibers to Regrow After Spinal Cord Injury 4Health News:A high BMI may not determine obesity, researchers say 2
Used to negotiate tortuous vessels....
BiodivYsio stent with biocompatible coating (phosphorylcholine)...
... The CYPHER Sirolimus-eluting Coronary Stent ... drug, called "sirolimus", a controlled-release ... delivery platform. Upon placement, sirolimus ... and impedes the process of ...
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
Medicine Products: